Prevalence of anti-lymphocyte IgM autoantibodies driving complement activation in COVID-19 patients.
Pérez-Díez A, Liu X, Calderon S, Bennett A, Lisco A, Kellog A, Galindo F, Memoli MJ, Rocco JM, Epling BP, Laidlaw E, Sneller MC, Manion M, Wortmann GW, Poon R, Kumar P, Sereti I.
Pérez-Díez A, et al. Among authors: poon r.
Front Immunol. 2024 Apr 17;15:1352330. doi: 10.3389/fimmu.2024.1352330. eCollection 2024.
Front Immunol. 2024.
PMID: 38694513
Free PMC article.